Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2484316 | 0.95 | TSHR (0.44) | TSHRACHEKCNN4CYP1A2KIF11 | |
| SCHEMBL31521772 | 0.85 | TSHR (0.47) | TSHRACHECYP1A2GABRA1GABRB2 | |
| SCHEMBL11528502 | 0.85 | TSHR (0.47) | TSHRACHECYP1A2GABRA1GABRB2 | |
| SCHEMBL2484319 | 0.85 | TRPA1 (0.40) | TSHRACHEKCNN4CYP1A2KIF11 | |
| SCHEMBL4122937 | 0.82 | TSHR (0.44) | TSHRACHEKCNN4CYP1A2KIF11 | |
| SCHEMBL11522521 | 0.80 | CYP1A2 (0.37) | TSHRACHECYP1A2KIF11LMNA | |
| SCHEMBL16933920 | 0.80 | TSHR (0.42) | TSHRACHEKCNN4CYP1A2KIF11 | |
| SCHEMBL11624548 | 0.79 | TSHR (0.38) | TSHRACHECYP1A2KIF11ESR1 | |
| SCHEMBL11622216 | 0.79 | MAPT (0.46) | TSHRCYP1A2KIF11ESR1ESR2 | |
| SCHEMBL11524798 | 0.79 | KIF11 (0.36) | TSHRACHEKCNN4KIF11GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113549145-B | Preparation method of somatostatin | 浙江湃肽生物有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-113549145-A | Preparation method of somatostatin | 浙江湃肽生物有限公司 | 2021-10-26 | — | — | CN | claimed |
| CN-113549145-B | Preparation method of somatostatin | 浙江湃肽生物有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-113549145-A | Preparation method of somatostatin | 浙江湃肽生物有限公司 | 2021-10-26 | — | — | CN | disclosed |
| CN-108295030-B | Bufalin micelle nanometer preparation and preparation method thereof | 香港理工大学深圳研究院 | 2020-04-07 | — | — | CN | disclosed |
| US-10413594-B2 | Conjugates of somatostatin analogues | PROLYNX LLC (US) | 2019-09-17 | — | — | US | disclosed |
| US-20180296648-A1 | CONJUGATES OF SOMATOSTATIN ANALOGUES | PROLYNX LLC (US) | 2018-10-18 | — | — | US | disclosed |
| US-10086049-B2 | Conjugates of somatostatin analogues | PROLYNX LLC (US) | 2018-10-02 | — | — | US | disclosed |
| CN-106232131-A | Conjugates of somatostatin and analogs thereof | 普洛林克斯有限责任公司 | 2016-12-14 | — | — | CN | disclosed |
| US-20160271227-A1 | CONJUGATES OF SOMATOSTATIN ANALOGUES | PROLYNX LLC (US) | 2016-09-22 | — | — | US | disclosed |
| EP-3060230-A1 | CONJUGATES OF SOMATOSTATIN AND ITS ANALOGS | Prolynx LLC (US) | 2016-08-31 | — | — | EP | disclosed |
| EP-2606911-A1 | Receptor And Antigen Targeted Prodrug | KTB Tumorforschungsgesellschaft mbH (DE) | 2013-06-26 | — | — | EP | disclosed |
| EP-2604283-A1 | Receptor And Antigen Targeted Prodrug | KTB Tumorforschungsgesellschaft mbH (DE) | 2013-06-19 | — | — | EP | disclosed |
| EP-2604284-A1 | Receptor And Antigen Targeted Prodrug | KTB Tumorforschungsgesellschaft mbH (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-20100111866-A1 | Receptor and Antigen Targeted Prodrug | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2010-05-06 | — | — | US | disclosed |
| EP-2129402-A2 | RECEPTOR AND ANTIGEN TARGETED PRODRUG | KTB Tumorforschungsgesellschaft mbH (DE) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008098788-A2 | RECEPTOR AND ANTIGEN TARGETED PRODRUG | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2008-08-21 | — | — | WO | disclosed |
| US-4136096-A | REACTING A 3-CYANO-PENAM WITH AN AZIDE | PFIZER INC. (US) | 1979-01-23 | — | — | US | disclosed |
| US-4081455-A | ANTIBACTERIAL | PFIZER INC. (US) | 1978-03-28 | — | — | US | disclosed |
| US-3992394-A | PENICILLIN INTERMEDIATES FOR BACTERICIDES | PFIZER INC. (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180296648-A1 | CONJUGATES OF SOMATOSTATIN ANALOGUES | SSTR4, SSTR3, SSTR2 | TSHR 36/4885ACHE 1696/4885KCNN4 2372/4885 |
| US-20160271227-A1 | CONJUGATES OF SOMATOSTATIN ANALOGUES | SSTR4, SSTR3, SSTR2 | TSHR 36/4885ACHE 1696/4885KCNN4 2372/4885 |
| US-10413594-B2 | Conjugates of somatostatin analogues | SSTR4, SSTR3, SSTR2 | TSHR 36/4885ACHE 1696/4885KCNN4 2372/4885 |
| US-10086049-B2 | Conjugates of somatostatin analogues | SSTR4, SSTR3, SSTR2 | TSHR 36/4885ACHE 1696/4885KCNN4 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.